For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220615:nRSO8778Oa&default-theme=true
RNS Number : 8778O Calnex Solutions PLC 15 June 2022
15 June 2022
Calnex Solutions plc
("Calnex" or the "Company")
Exercise of Options
Calnex Solutions plc (AIM: CLX), an established provider of test and
measurement solutions for the global telecommunications sector, announces that
the Company has today issued a total of 23,935 new ordinary shares of 0.125
pence each ("New Shares"), pursuant to the exercise of options issued under
the Company's EMI Share Option Plan.
Application will be made for the admission of the New Shares to trading on AIM
("Admission"). The New Shares will rank pari passu with the existing Ordinary
Shares and it is expected that Admission will become effective on or around
8.00 a.m. on 20 June 2022.
Following Admission, the Company's issued share capital will consist of
87,523,935 Ordinary Shares with voting rights. Calnex does not hold any
Ordinary Shares in treasury. This figure of 87,523,935 may be used by
shareholders in the Company as the denominator for the calculations by which
they will determine if they require to notify their interest in, or a change
to their interest in, the share capital of the Company under the UK Financial
Conduct Authority's Disclosure Guidance and Transparency Rules.
For more information, please contact:
Calnex Solutions plc Via Alma PR
Tommy Cook, Chief Executive Officer
Ashleigh Greenan, Chief Financial Officer
Cenkos Securities plc - NOMAD +44 (0)131 220 6939
Derrick Lee, Peter Lynch
Alma PR + 44(0) 20 3405 0213
Caroline Forde, Hannah Campbell, Joe Pederzolli
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END IOEEAKKLFADAEFA